Abstract
Abstract
During the first wave of the pandemic (March 2020-July 2020), it was postulated that there may be an increased risk of gastrointestinal bleeding (GIB) due to COVID-related inflammatory effects on the intestinal mucosa, as well as microthrombi from the hypercoagulable state induced by COVID. We performed a retrospective, multi-center, 1:2 case-control study to review 122 COVID-positive patients and 269 patients without COVID. There were no significant differences between the COVID and non-COVID patients for increased risk of GI bleeding. We concluded that despite the altered pathophysiology of the culprit lesions due to COVID infection, the same standard medical and endoscopic management strategies should be employed.
Publisher
Research Square Platform LLC
Reference18 articles.
1. Clinical Features and Pathophysiological Mechanisms of COVID-19-associated Gastrointestinal Manifestations;Aslan AT;Euroasian J Hepatogastroenterol,2021
2. Gastrointestinal bleeding in patients with coronavirus disease 2019: a matched case-control study;Martin TA;American Journal of Gastroenterology,2020
3. Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study;Trindade AJ;Journal of Internal Medicine,2020
4. The Incidence and Mortality Impact of Gastrointestinal Bleeding in Hospitalized COVID-19 Patients;Makker J;Clin Exp Gastroenterol,2021
5. Incidence, clinical characteristics, risk factors, and outcomes of upper gastrointestinal bleeding in patients with COVID-19;González González R;Journal of Clinical Gastroenterology,2020